Trademark Overview
On Thursday, January 20, 2022, a trademark application was filed for DIAMOND THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the DIAMOND THERAPEUTICS trademark a serial number of 97229628. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Wednesday, April 10, 2024. This trademark is owned by Diamond Therapeutics Inc.. The DIAMOND THERAPEUTICS trademark is filed in the Pharmaceutical Products, Computer & Software Products & Electrical & Scientific Products, Medical Instrument Products, Advertising, Business and Retail Services, Transportation & Storage Services, Computer & Software Services & Scientific Services, Personal, Legal & Social Services, Education & Entertainment Services, and Treatment & Processing of Materials Services categories with the following description:
Education services, namely providing computer training for brain and neural activity, providing information regarding psychiatric therapies and pharmacology in the field of psychedelic-based mental health treatments for humans
Custom manufacture for others of psychedelic-based pharmaceuticals, pharmaceutical drugs, therapeutic pharmaceuticals, and health care products namely, central nervous system health care products used to improve, treat, and prevent mental health diseases, disorders, conditions, and ailments in humans; Custom manufacture for others of psychedelic-based pharmaceuticals, drugs, therapeutic pharmaceuticals, and health care products used to treat mental conditions, illnesses, and disorders in humans
Downloadable computer applications for monitoring, sensing, stimulating, measuring, and training brain and neural activity during use of psychedelic-based pharmaceuticals, pharmaceutical preparations and products in humans; downloadable computer applications for use in therapy of cognitive states during use of psychedelic-based pharmaceuticals, pharmaceutical preparations and products in humans; downloadable computer software applications for monitoring, sensing, stimulating, measuring, and training brain and neural activity during use of psychedelic-based pharmaceuticals, pharmaceutical preparations and products in humans; downloadable computer software applications for use in therapy of cognitive states during use of psychedelic-based pharmaceuticals, pharmaceutical preparations and products in humans; medical systems comprising software and/or hardware for monitoring, sensing, stimulating, measuring, and training brain and neural activity during use of psychedelic-based pharmaceutic...
Warehousing services, namely, distribution of psychedelic-based pharmaceuticals, pharmaceutical drugs, therapeutic pharmaceuticals, and health care products, namely, central nervous system health care products used to improve, treat, and prevent diseases, disorders, conditions, and ailments in humans; Distribution services, namely, delivery of psychedelic-based pharmaceuticals, pharmaceutical drugs, therapeutic pharmaceuticals, and health care products, namely, central nervous pharmaceuticals, pharmaceutical drugs, therapeutic pharmaceuticals, and health care products, namely, central nervous system health care products used to improve, treat, and prevent diseases, disorders, conditions, and ailments in humans
Psychedelic-based pharmaceuticals, pharmaceutical preparations and products for the treatment of central nervous system conditions, illnesses, and disorders in humans; psychedelic-based medicines for the treatment of central nervous system conditions, illnesses, and disorders; neurogenerative psychedelic-based pharmaceutical drugs for use in humans; serotonin receptor agonists and antagonist pharmaceutical drugs for use in humans; abuse deterrent products, namely, very low-dose, low dose, and extended release psychedelic-based pharmaceutical preparations to avoid overdosing or diversion of psychedelic drugs; psychedelic-based pharmaceutical preparations for managing a mental, a behavioral, or a neuropsychiatric condition, or its symptoms, namely, motivation, attention, accuracy, response speed, perseverance, cognitive engagement, executive function, mood, behavior; therapeutics for the treatment of mental conditions, illnesses, and disorders in humans
Wholesale distributorship featuring psychedelic-based pharmaceuticals, drugs, therapeutic pharmaceuticals, and health care products used to improve, treat, and prevent diseases, disorders, conditions, and ailments in humans; developing marketing strategies for others in the field of psychedelic-based pharmaceuticals, drugs, and health care products used to improve, treat and prevent diseases, disorders, conditions, and ailments in humans; wholesale distributorship featuring distribution and sale of psychedelic-based pharmaceuticals, drugs, therapeutic pharmaceuticals, and health care products used to treat mental conditions, illnesses, and disorders in humans; developing marketing strategies for others in the field of psychedelic-based pharmaceuticals, drugs, therapeutic pharmaceuticals, and health care products used to treat mental conditions, illnesses, and disorders in humans
Licensing of proprietary information in the field of psychedelic-based pharmaceuticals, drugs, therapies, and health care products used to improve, treat, and prevent mental health diseases, disorders, conditions, illnesses, and ailments
Electroencephalogram (EEG) devices namely electroencephalography (EEG) device comprising a sensor for monitoring and measuring brain and neural activity for medical diagnostic purposes during use of psychedelic-based pharmaceuticals, pharmaceutical preparations and products in humans; medical devices for monitoring, sensing, measuring, and training brain and neural activity; medical devices in the nature of elecroencephalogram (EEG), electrocardiogram (EKG), magnetoencephalogram (MEG), functional near-infrared spectroscopy (fNRIS), positron emission tomography (PET), transcranial functional ultrasound, imaging devices, pupillometers, voltmeters, photodiodes, complementary metal-oxide semiconductor (CMOS), ultrasound, piezoelectric resonant devices, lead zirconate titanate (PZT), capacitive micromachined ultrasonic transducer (CMUT), micromembrane ultrasound transducer (PMUT), auditory stimulating devices, visual stimulating devices, sleep monitoring devices, thermometers, heart monitor...
Psychedelic-based pharmaceutical research and development for humans; psychedelic-based pharmaceutical drug development for humans; psychedelic-based pharmaceutical research and development in the field of mental health treatments for humans; psychedelic-based drug discovery services for humans; consultancy pertaining to pharmacology in the field of psychedelic-based mental health treatments in humans; psychedelic-based medical research in the field of human mental health conditions, illnesses, and disorders; neuropsychiatric drug discovery services including pre-clinical and clinical pharmaceutical psychedelic-based drug development for humans; psychedelic-based pharmaceutical drug development and discovery including new chemical entities, neurogenerative drugs, serotonin receptor agonists and antagonist, abuse deterrent drugs, and pharmaceutical preparations for managing a mental, a behavioral, or a neuropsychiatric condition, or its symptoms in humans